Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
ADAR1 affects HCV infection by modulating innate immune response.
Positioning Europe for the EPITRANSCRIPTOMICS challenge.
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Antiviral treatment strategies based on gene silencing and genome editing.
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
SAMHD1 is active in cycling cells permissive to HIV-1 infection.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
Highlights of the 30th International Conference on Antiviral Research.
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.